Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACCESS: A Randomized, Multicenter, Single-Blinded Trial to Compare the Extrafemoral Closure Device Exo-Seal® and the Collagen-based Intravascular Device Angio-SealTM for Arterial Puncture Site Closure.

NCT01669382 is registered in ClinicalTrials.gov with University Hospital Erlangen as lead sponsor.

NCT NCT01669382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01669382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACCESS: A Randomized, Multicenter, Single-Blinded Trial to Compare the Extrafemoral Closure Device Exo-Seal® and the Collagen-based Intravascular Device Angio-SealTM for Arterial Puncture Site Closure.
Lead sponsor
University Hospital Erlangen
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2012
Completion date
September 30, 2012
Enrollment
304 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, stable angina pectoris